Most Omicron-related cognitive decline reverses over 2 years, study finds

A multicenter Chinese study of hospitalized COVID-19 survivors found that most people kept or regained cognitive function two years after Omicron infection, while a smaller group faced lasting decline. Older age, reinfection, severe illness and hypertension raised risk, suggesting clinicians may need to focus follow-up on patients most likely to progress.

Why it matters: - Cognitive problems after COVID-19 can affect attention, memory and executive function, and long-term uncertainty has been a major concern for hospitalized survivors. - The study suggests many post-Omicron cognitive changes improve over time, but a smaller high-risk group may still face persistent or worsening deficits. - The findings support risk-based monitoring, rehabilitation and vaccine-focused prevention for patients most likely to decline.

What happened: - Researchers led by Professor Yan Wan and Professor Bo Hu at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology followed 3,419 patients hospitalized with COVID-19 during the Omicron-predominant period from December 2022 to March 2023. - The cohort came from nine hospitals in China. - Cognitive function was assessed by telephone at 6 months and 2 years after infection. - The team used the Telephone Interview of Cognitive Status-40 and the Informant Questionnaire on Cognitive Decline in the Elderly. - Among 2,087 survivors who completed both assessments, the researchers sorted outcomes into stable, reversible decline, non-progressive decline and progressive decline. - The study was published online July 16, 2026, in Neuroprotection.

The details: - Two years after discharge, 67.1% of participants maintained stable cognition. - Another 22.0% showed reversible cognitive decline. - Irreversible decline affected 10.8% of participants. - Within that group, 7.2% had non-progressive decline and 3.6% had progressive decline. - Participants with reversible decline improved by 3 points on the TICS-40, rising from 21.00 at 6 months to 24.00 at 2 years. - That improvement showed up in attention and calculation, delayed recall, registration, learning ability and executive function. - The progressive group fell by 4 points on the TICS-40, from 17.00 to 13.00. - Progressive decline was strongest in attention and calculation, delayed recall and registration. - Age 60 years or older was linked to more than fourfold higher odds of progressive decline. - Each additional infection more than doubled the odds of progressive decline. - Severe COVID-19, hypertension, longer hospitalization and white matter lesions were also independently associated with progressive decline. - Each additional year of education and a higher number of vaccine doses were protective. - The original paper is titled “Post-Omicron cognitive decline is largely reversible: Two-year multicenter cohort study of domain-specific outcomes in hospitalized patients.” - The paper’s DOI is 10.1002/nep3.70050.

Between the lines: - The results contrast with earlier SARS-CoV-2 variants, which were more often tied to persistent cognitive deficits. - Omicron’s generally milder disease pattern appears to have left open the possibility of recovery, especially for patients without major risk factors. - The protective link with vaccination and education suggests both prevention and cognitive reserve may matter in long-term recovery. - The domain-specific findings point to rehabilitation that targets attention, memory and executive function rather than treating post-COVID cognitive problems as a single syndrome.

What's next: - The researchers say future studies should include longer follow-up and in-person neuropsychological testing to track cognitive trajectories beyond 2 years. - Clinicians may use age, reinfection history, illness severity, vascular health and brain imaging to decide who needs closer follow-up. - Hospitals and rehabilitation teams may prioritize older adults and patients with white matter lesions or other risk factors for ongoing assessment. - The findings may also encourage broader prevention efforts, including vaccination, to lower the chance of progressive decline.

The bottom line: - Most hospitalized Omicron survivors in this study either stayed cognitively stable or improved, but older, reinfected and medically vulnerable patients still faced a meaningful risk of lasting decline.